Key facts
- Gyenno Science’s last known valuation is $21.2M (Jan 2016).
- It has raised $23.0M; the latest was Later Stage VC in Nov 2025.
- Notable investors include F-Prime Capital, Qiming Venture Partners, Eight Roads, In Capital, ABC Capital — 10 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 10 names
- ·Watchlist + deal alerts for Gyenno Science
- ·The full record, as it builds
Funding rounds
No funding rounds for Gyenno Science are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Gyenno Science
Developer of intelligent medical devices designed for the treatment of Parkinson's and motor dysfunction. The company offers research and development of intelligent monitoring and assistant devices, and it develops systematic solutions to functional disorders for patients with Parkinson's and motor dysfunction, enabling patients to monitor their physical activities and facilitate their movements.
- Sector
- Healthcare
- HQ
- Shenzhen, China
- Founded
- 2013
- Employees
- 63
- Website
- gyenno.com/
- Ownership
- Privately Held (backing)
Gyenno Science doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Gyenno Science shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Gyenno Science in its N-PORT filings yet. We sweep new filings monthly.